Publications by authors named "Fernando Salangsang"

Claim this Profile
A
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignancies.
Adila Izgutdina, Tasfia Rashid, William C Temple, Sarah Aminov, Bonell Patiño-Escobar, Fernando Salangsang

J Immunother Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bicistronic CAR T-cells Against CD70 & Active Integrin β2 Overcome Antigen Heterogeneity and Preserve Safety in Acute Myeloid Leukemia.
Amrik S Kang, Haley Johnson, Nicole Lei, Jeremiah Wong, Nabeel Razi, Fernando Salangsang

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells.
Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, Amrik S Kang, Nikhil Chilakapati, Fernando Salangsang

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myeloma.
Nikhil Chilakapati, Bonell Patiño-Escobar, Emily Y Chen, Radhika Dalal, Jonathan de Montagnac, Fernando Salangsang

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies.
Adila Izgutdina, Tasfia Rashid, William C Temple, Bonell Patiño-Escobar, Sujata Walunj, Fernando Salangsang

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoproteomics reveals immunogenic and tumor-associated cell surface substrates of ectokinase CK2α.
Corleone S Delaveris, Sophie Kong, Jeff Glasgow, Rita P Loudermilk, Lisa L Kirkemo, Fernando Salangsang

Cell Chem Biol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoproteomics reveals immunogenic and tumor-associated cell surface substrates of ectokinase CK2α.
Corleone S Delaveris, Sophie Kong, Jeff Glasgow, Rita P Loudermilk, Lisa L Kirkemo, Fernando Salangsang

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.
Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, Amrik Kang, Nikhil Chilakapati, Fernando Salangsang

bioRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural surfaceomics reveals an AML-specific conformation of integrin β as a CAR T cellular therapy target.
Kamal Mandal, Gianina Wicaksono, Clinton Yu, Jarrett J Adams, Michael R Hoopmann, Fernando Salangsang

Nat Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies.
William C Temple, Matthew A Nix, Akul Naik, Adila Izgutdina, Benjamin J Huang, Fernando Salangsang

J Immunother Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins.
Katarina Pance, Josef A Gramespacher, James R Byrnes, Fernando Salangsang, Juan-Antonio C Serrano

Nat Biotechnol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
Hui Gao, Joshua M Korn, Stéphane Ferretti, John E Monahan, Youzhen Wang, Fernando Salangsang

Nat Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance.
Meghna Das Thakur, Fernando Salangsang, Allison S Landman, William R Sellers, Nancy K Pryer

Nature· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts.
Pietro Taverna, Katherine Rendahl, Dragana Jekic-McMullen, Yi Shao, Kim Aardalen, Fernando Salangsang

Biochem Pharmacol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis